The immunotoxin, expressed and purified from Escherichia coli, was tested in vitro on HER2-positive breast cancer cell lines, showing increased cytotoxicity and specificity towards HER2-expressing cells compared to other cell lines. The gene discussed is ERBB2; the disease is breast carcinoma.